Tea will be served at 10:45 a.m., immediately preceding the seminar.
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...
Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.
Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.
The Aviram Lab investigates the molecular mechanisms that protect microorganisms from their own pathogenic invaders.
Thursday, June 12, 2025 - 2:00 p.m. to 3:00 p.m.
Tea will be served at 1:45 p.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.
This seminar is open to the research community.
A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results